These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 22349148)

  • 1. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.
    Carbajo-Lozoya J; Müller MA; Kallies S; Thiel V; Drosten C; von Brunn A
    Virus Res; 2012 Apr; 165(1):112-7. PubMed ID: 22349148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.
    Carbajo-Lozoya J; Ma-Lauer Y; Malešević M; Theuerkorn M; Kahlert V; Prell E; von Brunn B; Muth D; Baumert TF; Drosten C; Fischer G; von Brunn A
    Virus Res; 2014 May; 184():44-53. PubMed ID: 24566223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.
    Berthold EJ; Ma-Lauer Y; Chakraborty A; von Brunn B; Hilgendorff A; Hatz R; Behr J; Hausch F; Staab-Weijnitz CA; von Brunn A
    Front Cell Infect Microbiol; 2022; 12():958634. PubMed ID: 36211973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
    Schneider WM; Luna JM; Hoffmann HH; Sánchez-Rivera FJ; Leal AA; Ashbrook AW; Le Pen J; Ricardo-Lax I; Michailidis E; Peace A; Stenzel AF; Lowe SW; MacDonald MR; Rice CM; Poirier JT
    Cell; 2021 Jan; 184(1):120-132.e14. PubMed ID: 33382968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.
    Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses.
    Wang Y; Li P; Solanki K; Li Y; Ma Z; Peppelenbosch MP; Baig MS; Pan Q
    Virology; 2021 Dec; 564():33-38. PubMed ID: 34619630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral strategies against human coronaviruses.
    Pyrc K; Berkhout B; van der Hoek L
    Infect Disord Drug Targets; 2007 Mar; 7(1):59-66. PubMed ID: 17346212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
    Ma-Lauer Y; Zheng Y; Malešević M; von Brunn B; Fischer G; von Brunn A
    Antiviral Res; 2020 Jan; 173():104620. PubMed ID: 31634494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
    Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies.
    Sastre P; Dijkman R; Camuñas A; Ruiz T; Jebbink MF; van der Hoek L; Vela C; Rueda P
    Clin Vaccine Immunol; 2011 Jan; 18(1):113-8. PubMed ID: 21084464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.
    Chan RW; Chan MC; Agnihothram S; Chan LL; Kuok DI; Fong JH; Guan Y; Poon LL; Baric RS; Nicholls JM; Peiris JS
    J Virol; 2013 Jun; 87(12):6604-14. PubMed ID: 23552422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.
    Hofmann H; Pyrc K; van der Hoek L; Geier M; Berkhout B; Pöhlmann S
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7988-93. PubMed ID: 15897467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E.
    Tang BS; Chan KH; Cheng VC; Woo PC; Lau SK; Lam CC; Chan TL; Wu AK; Hung IF; Leung SY; Yuen KY
    J Virol; 2005 May; 79(10):6180-93. PubMed ID: 15858003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
    Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
    PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A inhibits the replication of diverse coronaviruses.
    de Wilde AH; Zevenhoven-Dobbe JC; van der Meer Y; Thiel V; Narayanan K; Makino S; Snijder EJ; van Hemert MJ
    J Gen Virol; 2011 Nov; 92(Pt 11):2542-2548. PubMed ID: 21752960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63.
    Dijkman R; Jebbink MF; Deijs M; Milewska A; Pyrc K; Buelow E; van der Bijl A; van der Hoek L
    J Gen Virol; 2012 Sep; 93(Pt 9):1924-1929. PubMed ID: 22718567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.
    Peters HL; Jochmans D; de Wilde AH; Posthuma CC; Snijder EJ; Neyts J; Seley-Radtke KL
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2923-6. PubMed ID: 26048809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.